|
Methodology
Order
Report
onlne.
Note: This report has
been updated (and expanded) by the February 2007 report, "Worldwide
Surgical Sealants, Glues & Wound Closure Market, 2007-2011." See
link.
Worldwide Surgical Sealants, Glues and Wound
Closure Market
January 2005
Report #S122
· 214 pages
· 58 Exhibits
· 56 Company Profiles
· Report #S122
This report details the complete range of sealants &
glues technologies, from tapes, sutures and staples to hemostats, fibrin
sealants/glues and medical adhesive. The report examines the clinical and
technology developments underlying this huge and rapidly growing worldwide
market, with data on products in development and on the market; market size and
forecast; competitor market shares; competitor profiles; and market
opportunity.
Table of Contents
EXECUTIVE SUMMARY
An
Important Healthcare Segment
Background
Demographic trends
Patient Driven Product Selection
Mechanisms of Repair
Commercial Imperatives
Industry Consolidation
Clinical Caseload
Market Segmentation and Dynamics
New
Applications for Adjunctive Closure and Securement Products
Benefits of Adjunctive Surgical Closure and Securement Products
History of Use
Evolution of Commercial Markets for Sealants and Adhesives
Company Strategies — Overview
Section 1:
CLINICAL NEED, CASELOAD, AND PROCEDURE VOLUME
1.1 Anatomy and Physiology of Tissue Repair
1.1.1 Skin Surface Tissues and Organs
1.1.2 Internal Tissues and Organs
1.2 Wound Classification and Types
1.2.1 Classification Wound Characteristics Wound Etiology
1.2.2 Surgical Wounds
1.2.2.1 Cardiovascular
1.2.2.1.1
Introduction
1.2.2.1.2
Coronary Heart Disease
1.2.2.1.3
Myocardial Infarction
1.2.2.1.4
Congestive Heart Failure
1.2.2.1.5
Dysfunctional Heart Valves
1.2.2.1.6
Peripheral Vascular Disorders
1.2.2.1.7
Abnormal Aortic Aneurysms
1.2.2.1.8
Drivers of Caseloads for Cardiac Surgery
1.2.2.2 Neurological
1.2.2.2.1
Introduction
1.2.2.2.2
Stroke
1.2.2.2.3
Parkinson’s Disease
1.2.2.2.4
Epilepsy
1.2.2.2.5
Traumatic Injury
1.2.2.2.6
Peripheral Nerve Treatment
1.2.2.2.7
Neurology Drivers
1.2.2.3 Orthopedic
1.2.2.3.1
Introduction
1.2.2.3.2
Cartilage Repair
1.2.2.3.3
Ligament Damage
1.2.2.3.4
Bone Graft Materials
1.2.2.3.5
Vertebral Disc Repair
1.2.2.3.6
Drivers of Orthopedic Surgery
1.2.2.4 Urological
1.2.2.4.1
Introduction
1.2.2.4.2
Incontinence
1.2.2.4.3
Drivers of Urological Surgery
1.2.2.5 Skin
1.2.2.5.1
Introduction
1.2.2.5.2
Burns
1.2.2.5.3
Pressure Ulcers
1.2.2.5.4
Diabetic Ulcers
1.2.2.5.5
Venous Ulcers
1.2.2.5.6
Plastic Surgery
1.2.2.6 Fibrin Glue and Sealants as a Vital Tools in the Surgeon’s
Armamentarium
1.2.2.7 Uses of High Strength Glues in Surgical
Applications
Section 2:
SCIENCE, TECHNOLOGY, DEVELOPMENT, CLINICAL AND REGULATORY CHALLENGES
2.1 Tissue Healing
2.1.1 Hemostasis
2.1.2 Proliferative Phase
2.1.3 Factors That Affect Healing
2.2 Development, Clinical, Regulatory and Cost-Effectiveness Challenges
2.2.1 Development
2.2.2 Delivery Systems
2.2.3 Cost Effectiveness
2.2.4 Clinical
2.2.5 Regulatory
Section 3:
PRODUCTS, TECHNOLOGIES, AND FORECAST OPPORTUNITY
3.1 Overview
3.2 Sutures and Staples
3.2.1 Competitors and Products
3.2.1.1 Overview
3.2.1.2 Companies
3.2.2 Products in Development
3.2.3 Market Analysis and Forecast
3.3 Tapes
3.3.1 Competitors and Products
3.3.2 Products in Development
3.3.3 Market Analysis and Forecast
3.4 Hemostats
3.4.1 Competitors and Products
3.4.2 Products in Development
3.4.3 Market Analysis and Forecasts
3.5 Fibrin and Sealant Products
3.5.1 Overview
3.5.2 Competitors and Products
3.5.3 Products in Development
3.5.4 Fibrin and Sealant Market and Competitive Activity
3.6 High-Strength Medical Adhesives
3.6.1 Competitors and Products
3.6.2 Products in Development
3.6.3 Market Analysis and Forecasts
3.7 Post-Surgical Adhesion Prevention
3.7.1 Competitors and Products
3.7.2 Products in Development
3.7.3 Market Analysis and Forecasts
Section 4:
COMPANY PROFILES
4.1 Angiotech Pharmaceuticals Inc
4.2 Advanced Medical Solutions plc
4.3 Anika Therapeutics Inc.
4.4 ARC Pharmaceuticals
4.5 Aventis Behring
4.6 Bard Medical Division / C.R. Bard, Inc.
4.7 Baxter International Inc.
4.8 ZLB Behring
4.9 Biocoral Inc.
4.10 Biovascular Inc. ((Synovis Life Technologies)
4.11 B. Braun Melsungen AG
4.12 Chemence Limited
4.13 Closure Medical Corporation
4.14 Cohesion Technologies Inc.
4.15 Collagen Matrix Inc.
4.16 Confluent Surgical Inc.
4.17 CryoLife, Inc.
4.18 (CSMG) Consortium Service Management Group
4.19 CuraMedical BV
4.20 Johnson & Johnson (Ethicon)
4.21 Fehling Medical AG/Berlin Heart
4.22 FibroGen, Inc.
4.23 Fidia Advanced Biopolymers
4.24 Focal Inc./Genzyme BioSurgery
4.25 Fusion Medical Technologies Inc./Baxter
4.26 FzioMed Inc.
4.27 GEM SRI
4.28 Genzyme Biosurgery Inc.
4.29 Glustitch Inc.
4.30 Haemacure Corporation
4.31 Harvest Technologies Corporation
4.32 HemCon, Inc.
4.33 Integra Life Sciences Holdings Corp.
4.34 Interpore Cross International/Biomet
4.35 Kensey Nash Corporation
4.36 King Pharmaceuticals
4.37 Lifecore Biomedical, Inc.
4.38 Marine Polymer Technologies
4.39 Medafor, Inc.
4.40 MedLogic Global Corporation/Advanced Medical Solutions plc
4.41 Nycomed Pharma
4.42 Onux Medical Inc.
4.43 Organogenesis Inc.
4.44 Pharming Group NV
4.45 Plasmaseal
4.46 Polyganics
4.47 Smith & Nephew plc
4.48 Spiration Inc.
4.49 Synovis Life Technologies
4.50 Thermogenesis Corporation
4.51 Tissuemed Ltd
4.52 Tyco International Inc.
4.53 US Biomedical, Inc. (Life Medical Sciences Inc.)
4.54 US Surgical Corp.
4.55 Vivolution
List of Exhibits
Exhibit ES-1: Recent Acquisitions within the Securement Segment
Exhibit ES-2: Introduction of New Securement Technologies to the U.S. Market
Exhibit ES-3: Definition of Surgical Closure and Securement Products
Exhibit ES-4: Availability of Sealant Products from Selected Companies
Exhibit ES-5: Availability of High Strength Glue Products from Example
Companies
Exhibit ES-6: Incidence of Two Example Surgical Procedures with High
Requirement for Adjunctive Products for Surgical Closure and Securement
Exhibit ES-7: U.S. FDA Approved Uses of Sealants, Glues, and Hemostats
Exhibit ES-8: Synthetic and Biological Sealant Competitors (Non-Fibrin
Sealants)
Exhibit ES-9: Selected High Strength Adhesive Companies and Their Strategies
Exhibit ES-10: Selected Sealant Product Companies and Their Strategies
Exhibit ES-11: Worldwide Growth in the Securement and Closure Market,
2004-2014
Exhibit 1-1: Skin Structure Illustrating Major Organelles and Skin Layers
Exhibit 1-2: Classification of Wounds by Morphology
Exhibit 1-3: Severity Classification of Wounds
Exhibit 1-4: Current Uses of Adjunctive Surgical Closure Products
Exhibit 1-5: 2004, Worldwide Wound Incidence by Etiology
Exhibit 1-6: Criteria for Adjunctive Use of Hemostats, Sealants, High
Strength Adhesives and Adhesion Prevention Products for Surgery
Exhibit 1-7: Surgical Procedures with Potential Requirements for Hemostats,
Sealants, High Strength Adhesives and Adhesion Prevention Products
Exhibit 1-8: Potential for Cardiovascular Applications, Incidences of
Applicable Surgical Disorders (000s), 2004
Exhibit 1-9: Potential for Neurological Applications, Incidences of
Applicable Disorders (000s), 2004
Exhibit 1-10: Potential for Orthopedic Applications, Numbers of Major
Surgical Interventions (000s), 2004
Exhibit 1-11: Potential for Urological Applications, Incidence of Applicable
Disorders (000s), 2004
Exhibit 1-12: Potential for Dermal Repair, Incidence of Applicable Disorders
(000s), 2004
Exhibit 1-13: Applications of Fibrin and Other Sealants
Exhibit 1-14: Surgical Procedures Using Fibrin and Other Sealant Products
(1990-2002)
Exhibit 1-15: Surgical Indications for High Strength Glues (Europe - 2002)
Exhibit 2-1: Factors That Impact on Wound Healing
Exhibit 2-2: Timescales for Development of Closure and Sealant Products
Exhibit 2-3: Variables associated with Clinical Evaluation of Closure and
Securement, and Related Products
Exhibit 2-3: Clinical Development and Approvals (USA)
Exhibit 3-1: Companies Commercializing Technologies in the Surgical Suture
and Staples Category
Exhibit 3-2: Worldwide Sutures and Staples, Market Forecast, 2004-2014
Exhibit 3-3: 2004, Worldwide Suture and Staples Market, Share by Supplier
Exhibit 3-4: Companies Commercializing First Aid Technologies That Are Often
Used as Tapes for Closure
Exhibit 3-5: Worldwide Tapes Market Forecast, 2004-2014
Exhibit 3-6: 2004, Worldwide Tapes for Closure Market Share by Supplier
Exhibit 3-7: Companies Commercializing Technologies in the Hemostat Category
Exhibit 3-8: Worldwide Hemostats Market Forecast, 2004-2014
Exhibit 3-9: 2004, Worldwide Hemostats Market Share by Supplier
Exhibit 3-10: Companies Commercializing Technologies in the Sealants Category
Exhibit 3-11: Worldwide Sealants Market Forecast, 2004-2014
Exhibit 3-12: 2004, Worldwide Sealants Market Share by Supplier
Exhibit 3-13: Companies Commercializing Cyanoacrylate-based High Strength
Medical Adhesives
Exhibit 3-14: Worldwide High Strength Glues Market Forecast, 2004-2014
Exhibit 3-15: 2004, Worldwide High Strength Glues Market Share by Supplier
Exhibit 3-16 Regulatory Status of Surgical Sealant Products
Exhibit 3-17: Companies Commercializing Technologies in the Post-Operative
Adhesion Category
Exhibit 3-18: Worldwide Post Operative Adhesion Prevention Market Forecast,
2004-2014
Exhibit 3-19: Worldwide Post Operative Adhesion Prevention Market Share by
Supplier
Exhibit 4.1: Anika Financial Summary
Exhibit 4-2: Baxter International Healthcare – Top-line financial data, 2003
and 2003
Exhibit 4-3: B. Braun Financial Data
Exhibit 4-4: Closure Medical Financial Figures
Exhibit 4-5: CryoLife Inc, Financial Summary
Exhibit 4-6: Johnson & Johnson Headline Financial Data, Third Quarter 2004
(billions of dollars)
Exhibit 4-7: Haemacure Corporation Financial Data, Third Quarter 2004
Exhibit 4-8: Integra Life Sciences Holdings Corp. Financial Results for 2004
and 2003
Exhibit 4-9: Pharming Group Results for Nine months of 2004 and 2003
Exhibit 4-10: Synovis Life Technologies Inc, Financial data for Years Ending
October 31st 2004 and 2003
Appendix: List of Companies
Worldwide Surgical Sealants, Glues & Wound Closure, 2004-2014,
January 2005
Price:
$1,750 (print or PDF) or $1,950 (print and PDF)
Add $1,500 for site license
Order report
online.
Methodology.
MedMarket Diligence Reports are
produced through primary and secondary research. Data is gathered from
published sources on products and technologies on the market and under
development. Clinicians and industry representatives are
interviewed for their knowledge and insights on product development,
market development, clinical practice and trends associated with the
evolving use of technologies. Secondary data is used to corroborate
and support assessments and projections. Reports are written and
researched by industry insiders, whose familiarity with the companies,
industry dynamics and other marketplace specifics facilitate the
research process and ensure high quality and thorough reports. |
Contact: Patrick Driscoll, (949) 859-3401.
Copyright © 2006 MedMarket Diligence, LLC. All rights reserved.
Revised:
09/22/08
|
